Middle East Standoff Deepens Trump Rejects Irans Counteroffer Strait of Hormuz Tensions Escalate Core Inflation Rises to 32 in March Q1 Growth Misses Expectations as Oil Surge Puts Fed in a Bind Wallbox WBX Slips 109 Testing 258 Support 20260515 Organon OGN Holds 1338 Direction Awaited 20260515 GitHub Faces Headwinds in AI Coding Race as Outages and New Rivals Challenge Microsofts Ambitions Bahrain Minister Hails UKGulf Trade Deal as Monumental Achievement for Both Sides India Plans Major Overhaul of Tax Administration to Facilitate Smooth GST Rollout Canaccord Lowers Regeneron Price Target After Disappointing Phase 3 Trial Outcome Reliance Industries Boosts National Exchequer Contribution to Rs 216 Lakh Crore in FY26 AI Gurus Charge Wall Street Banks 25000 a Day for Advisory Services XNCR Q1 2026 Earnings Earnings Miss by Wide Margin as Losses Deepen Hamilton Lane HLNE Q1 2026 Earnings EPS Beat Drives Modest Stock Gain CRNT Q1 2026 Earnings EPS Beats Estimates Stock Rises ROST Q1 2026 Earnings EPS Beats Estimates by 145 Amid Cautious Consumer Environment NCTY Q1 2012 Earnings Narrower Loss Beats Estimates but Stock Slides KUST Q4 2025 Earnings EPS Misses Estimates by a Wide Margin Amid Operational Challenges Skye Bioscience SKYE Holds Above Support After Modest Gain Exelon EXC Edges Lower as Utilities Sector Faces Mixed Sentiment AdaptHealth Corp AHCO Slips 177 as Stock Tests Key Support Zone Nexgen Energy NXE Surges 281 to 1096 Amid Renewed Uranium Interest Ames National Corporation ATLO Edges Lower as Price Action Remains RangeBound Aurora Cannabis ACB Slips 28 as Shares Test Key Support Zone WD40 Company WDFC Holds Steady Near Support as Trading Range Persists Rumble Inc RUM Edges Higher as Support Holds Near 779 Ameriprise Financial AMP Edges Higher as Support Holds Resistance Ahead Civista Bancshares CIVB Holds Near Support Amid Modest Decline UK Heatwave and Port Queues Travel Disruption May Impact Holiday Industry NAMS Q1 2026 Earnings Narrowed Loss Per Share Surpasses Expectations Amid Continued Pipeline Development Radiopharm Theranostics RADX Holds Steady at 449 Consolidation Phase for Radiopharma Play